Ontology highlight
ABSTRACT: Background
Melioidosis is an infectious disease caused by the bacterium Burkholderia pseudomallei. The two stages of melioidosis treatment are the intense intravenous phase and the oral eradication phase. Although co-trimoxazole has been in use for several years, the literature does not demonstrate uniformity of the drug doses, combinations, or durations suitable for the eradication phase of melioidosis. The safety profile of co-trimoxazole was not documented in the literature, nor have systematic studies of its effectiveness been done. This systematic review sought to study on the dose, duration and combination of co-trimoxazole therapy in view of clinical efficacy and safety in the eradication phase of melioidosis.Main body
This systematic review included all of the publi
SUBMITTER: Keragala KARK
PROVIDER: S-EPMC10436656 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature